Ping Huang

Associate Director at Exelixis

Ping Huang's Professional Contact Details

Email (Verified)

****@exelixis.com

Get Email Address

(650) 837-7000

Location

San Francisco, California, US

Company

Exelixis

Person Seniority

director

Ping Huang's Current Company Details

Exelixis

South San Francisco, California, US • 394 Employees

biotechnology

Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following early work in model genetic systems, we established a broad drug discovery and development platform that has served as the foundation for our continued efforts to bring new cancer therapies to patients in need. We discovered our lead compounds, cabozantinib and cobimetinib, and advanced them into clinical development before entering into partnerships with leading biopharmaceutical companies in our efforts to bring them to patients globally. With growing revenues from the three resulting commercialized products, we are reinvesting in our business to maximize the potential of our pipeline, which we intend to supplement with targeted business development activities and internal drug discovery â€“ all to deliver the next generation of Exelixis medicines and help patients recover stronger and live longer. For more information about Exelixis, please visit www.exelixis.com or follow @ExelixisInc on Twitter.

Public Symbol

EXEL

Founded Year

1994

Organization Website

exelixis.com

Organization Languages

English

Organization Revenue

37200

Current Technologies

rackspace mailgun